Circulating Levels of IL‐6 Receptor and gp130 and Long‐Term Clinical Outcomes in ST‐Elevation Myocardial Infarction

Circulating Levels of IL‐6 Receptor and gp130 and Long‐Term Clinical Outcomes in ST‐Elevation Myocardial Infarction

BackgroundReports on soluble interleukin‐6 (IL‐6) receptor (sIL‐6R) and glycoprotein 130 (sgp130) in ST‐elevation myocardial infarction (STEMI) are few and include a small number of patients. The aim of this study was to investigate the possible association between levels of these biomarkers in the...

Full description

Bibliographic Details
Main Authors:	Vibeke N. Ritschel, Ingebjørg Seljeflot, Harald Arnesen, Sigrun Halvorsen, Jan Eritsland, Morten W. Fagerland, Geir Ø. Andersen
Format:	Article
Language:	English
Published:	Wiley 2016-06-01
Series:	Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:	inflammation interleukins myocardial infarction prognosis
Online Access:	https://www.ahajournals.org/doi/10.1161/JAHA.115.003014

Similar Items

Glucose associated NETosis in patients with ST-elevation myocardial infarction: an observational study
by: Ragnhild Helseth, et al.
Published: (2019-10-01)

Complement activation in association with clinical outcomes in ST-elevation myocardial infarction
by: Karsten E. Kluge, et al.
Published: (2022-12-01)

Abnormal glucose regulation in patients with acute ST- elevation myocardial infarction-a cohort study on 224 patients
by: Mangschau Arild, et al.
Published: (2009-01-01)

IgM antibodies against phosphorylcholine measured early after acute ST-elevation myocardial infarction in relation to atherosclerotic disease burden and long-term clinical outcome.
by: Eva Cecilie Knudsen, et al.
Published: (2019-01-01)

Interleukin-6 inhibition in ST-elevation myocardial infarction: Immune cell profile in the randomised ASSAIL-MI trial
by: Camilla Huse, et al.
Published: (2022-06-01)

Prothrombotic markers in patients with acute myocardial infarction and left ventricular thrombus formation treated with pci and dual antiplatelet therapy
by: Solheim Svein, et al.
Published: (2013-01-01)

CLINICAL AND PREDICTIVE VALUE OF SERUM INTERLEUKINE-18 IN ST ELEVATION MYOCARDIAL INFARCTION
by: M. V. Zykov, et al.
Published: (2015-11-01)

Osteoprotegerin levels in ST-elevation myocardial infarction: Temporal profile and association with myocardial injury and left ventricular function.
by: Christian Shetelig, et al.
Published: (2017-01-01)

Novel Insights Into the Effects of Interleukin 6 Antagonism in Non–ST‐Segment–Elevation Myocardial Infarction Employing the SOMAscan Proteomics Platform
by: Marc J. George, et al.
Published: (2020-06-01)

Interleukin‐1 Blockade Inhibits the Acute Inflammatory Response in Patients With ST‐Segment–Elevation Myocardial Infarction
by: Antonio Abbate, et al.
Published: (2020-03-01)

Comparison of Short Term In-Hospital Outcomes in patients presenting with ST-Elevation Myocardial Infarction Versus Non-ST-Elevation Myocardial Infarction
by: Masood Khan, et al.
Published: (2023-12-01)

Significance of C-Reactive Protein in Patients with ST-Elevation Myocardial Infarction Over Non-ST-Elevation Myocardial Infarction
by: Shahzadi Anum, et al.
Published: (2023-01-01)

ST-segment elevation myocardial infarction and the clinical significance of differentiated electrocardiogram
by: V. K. Tashchuk, et al.
Published: (2023-05-01)

Electrocardiographic localization of infarct related coronary artery in acute ST elevation myocardial infarction
by: C.S. Thejanandan Reddy, et al.
Published: (2013-07-01)

The NLRP3 inflammasome activation in subcutaneous, epicardial and pericardial adipose tissue in patients with coronary heart disease undergoing coronary by-pass surgery
by: Sissel Åkra, et al.
Published: (2022-04-01)

Differing Outcome of Experimental Autoimmune Encephalitis in Macrophage/Neutrophil- and T Cell-Specific gp130-Deficient Mice
by: Kristian Holz, et al.
Published: (2018-05-01)

Comparison of Short-Term Clinical Outcome of Non-ST Elevation versus ST Elevation Myocardial Infarction
by: Hakimeh Sadeghian, et al.
Published: (2009-04-01)

Comparison of Short-Term Clinical Outcome of Non-ST Elevation versus ST Elevation Myocardial Infarction
by: Elham Hakki, et al.
Published: (2009-06-01)

REGIONAL ALGORITHM OF CARE IN ST ELEVATION MYOCARDIAL INFARCTION
by: A. Yu. Vafin, et al.
Published: (2016-03-01)

Impact of ST‐Segment–Elevation Myocardial Infarction Regionalization Programs on the Treatment and Outcomes of Patients Diagnosed With Non–ST‐Segment–Elevation Myocardial Infarction
by: Juan Carlos C. Montoy, et al.
Published: (2021-02-01)

Myocardial infarction with simultaneous anterior and inferior ST‐segment elevation
by: Anna Meta Dyrvig Kristensen, et al.
Published: (2019-03-01)

Circulating Microvesicles in Association with the NLRP3 Inflammasome in Coronary Thrombi from STEMI Patients
by: Vibeke Bratseth, et al.
Published: (2022-09-01)

Genetic markers of risk for ST-elevated myocardial infarction
by: N. G. Lozhkina, et al.
Published: (2019-11-01)

In-hospital outcomes of ST elevation myocardial infarction in post-COVID-19 patients
by: M. G. Chashchin, et al.
Published: (2023-03-01)

Influence of renin-angiotensin-aldosterone system block on the systemic inflammation activity and left ventricle remodeling in patients with Q-myocardial infarction after thrombolysis
by: S. M. Kyselov
Published: (2015-06-01)

ST Elevation Myocardial Infarction Due to Carbon Monoxide Poisoning
by: Hayriye Gonullu, et al.
Published: (2011-08-01)

GP130 Cytokines in Breast Cancer and Bone
by: Tolu Omokehinde, et al.
Published: (2020-01-01)

The impact of cigarette smoking on infarct location and in-hospital outcome following acute ST-elevation myocardial infarction
by: Mehdi Toluey, et al.
Published: (2019-08-01)

Lysophospholipids as Predictive Markers of ST-Elevation Myocardial Infarction (STEMI) and Non-ST-Elevation Myocardial Infarction (NSTEMI)
by: Elin Chorell, et al.
Published: (2020-12-01)

Leukocyte telomere length and serum polyunsaturated fatty acids, dietary habits, cardiovascular risk factors and features of myocardial infarction in elderly patients
by: Are A. Kalstad, et al.
Published: (2019-12-01)

Contemporary approach to st elevation myocardial infarction in very young
by: R.P. Yalamanchi, et al.
Published: (2023-09-01)

Kounis Syndrome: Dexketoprofen-Associated ST-Elevation Myocardial Infarction
by: Aytekin Aksakal, et al.
Published: (2021-11-01)

The 12 lead Ecg in ST elevation myocardial infarction : a practical approach for clinicians /
by: 272978 Bayes de Luna, Antonio, et al.
Published: (2007)

Relationship between the infarct localization and left ventricular rotation parameters following acute ST-segment elevation myocardial infarction
by: Aykut Demirkiran, et al.
Published: (2020-04-01)

Peripheral Inflammatory Factors and Acute Myocardial Infarction Risk: A Mendelian Randomization Study
by: Yaxi Chen, et al.
Published: (2023-10-01)

Circulating fibrocyte levels correlate with infarct size in patients with ST elevation myocardial infarction treated with primary percutaneous coronary intervention
by: Mohammed Elzeneini, et al.
Published: (2021-12-01)

Changes in Lipoprotein(a) Levels in People after ST Elevation Myocardial Infarction—The STEMI-Lipids Study
by: Caren Sourij, et al.
Published: (2023-10-01)

Echocardiographic Evaluation of Right Ventricular Function in Patients Presenting with Acute ST-Elevation Myocardial Infarction
by: Rajeev Kumar Gupta, et al.
Published: (2022-01-01)

Performance of the ATRIA Bleeding Score in Predicting the Risk of In-Hospital Bleeding in Patients with ST-Elevation or Non-ST-Elevation Myocardial Infarction
by: Fethi Yavuz, et al.
Published: (2022-06-01)

The role of interleukin-18 in the metabolic syndrome
by: Seljeflot Ingebjørg, et al.
Published: (2010-03-01)